{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:44Z","timestamp":1793723804722,"version":"4.6.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.virol.2025.110438","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:13:47Z","timestamp":1738329227000},"page":"110438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["HBx protein as a therapeutic target for functional cure of hepatitis B virus infection"],"prefix":"10.1016","volume":"604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-1977","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110438_bib103","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2020-322571","article-title":"Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5\/6 complex and silencing of the viral genome in vivo","volume":"71","author":"Allweiss","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.virol.2025.110438_bib1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/gutjnl-2022-328380","article-title":"Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure","volume":"72","author":"Allweiss","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.virol.2025.110438_bib3","first-page":"75","article-title":"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis","volume":"103","author":"Benhenda","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.virol.2025.110438_bib2","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2025.110438_bib5","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/molecules24112163","article-title":"Botanical sources, chemistry, analysis, and biological activity of furanocoumarins of pharmaceutical interest","volume":"4","author":"Bruni","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2025.110438_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.09.050","article-title":"5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","volume":"721","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.virol.2025.110438_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2007.01.004","article-title":"RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma","volume":"253","author":"Cheng","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2025.110438_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx","volume":"74","author":"Cheng","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib9","article-title":"Hepatitis B virus entry, assembly, and egress","volume":"23","author":"Chuang","year":"2024","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.virol.2025.110438_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"42","author":"Dandri","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.virol.2025.110438_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsi\u00e8re","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110438_bib13","first-page":"807","article-title":"All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner","volume":"24","author":"Faluhelyi","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.virol.2025.110438_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virol.2025.110438_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jhep.2023.05.023","article-title":"Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: results from randomized clinical trials","volume":"79","author":"Gane","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib17","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/JVI.02196-09","article-title":"The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication","volume":"84","author":"Gearhart","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/v15071456","article-title":"All-trans retinoic acid inhibits hepatitis B virus replication by downregulating HBx levels via siah-1-mediated proteasomal degradation","volume":"15","author":"Han","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110438_bib19","article-title":"All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication","volume":"19","author":"Han","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110438_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00900-22","article-title":"Comparison of pharmacokinetics of the GalNAc-conjugated antisense oligonucleotide GSK3389404 in participants with chronic hepatitis B infection across the asia-pacific region","volume":"67","author":"Han","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110438_bib21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.24505","article-title":"Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner","volume":"54","author":"Han","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2025.110438_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2018.11.006","article-title":"5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice","volume":"161","author":"Han","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110438_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","article-title":"Therapeutic potential of coumarins as antiviral agents","volume":"123","author":"Hassan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virol.2025.110438_bib24","article-title":"Gambogic acid: a shining natural compound to nanomedicine for cancer therapeutics","volume":"1874","author":"Hatami","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.virol.2025.110438_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12929-020-00662-x","article-title":"HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice","volume":"27","author":"Horng","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.virol.2025.110438_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/microorganisms11030600","article-title":"Dynamics of hepatitis B virus covalently closed circular DNA: a mini-review","volume":"11","author":"Hu","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.virol.2025.110438_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18484","article-title":"SIAH2 suppresses c-JUN pathway by promoting the polyubiquitination and degradation of HBx in hepatocellular carcinoma","volume":"28","author":"Hu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.virol.2025.110438_bib28","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1128\/JVI.73.9.7231-7240.1999","article-title":"Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex","volume":"73","author":"Hu","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib29","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1128\/jvi.70.8.5582-5591.1996","article-title":"Proteasome complex as a potential cellular target of hepatitis B virus X protein","volume":"70","author":"Huang","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0014-5793(04)00113-9","article-title":"Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs","volume":"560","author":"Hung","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virol.2025.110438_bib32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2025.110438_bib33","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1128\/JVI.02020-06","article-title":"Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo","volume":"81","author":"Keasler","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1006\/bbrc.1999.0537","article-title":"Repression of hepatitis B virus X gene expression by hammerhead ribozymes","volume":"257","author":"Kim","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2025.110438_bib100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13337-024-00895-6","article-title":"New thiourea derivatives that target the episomal silencing SMC5 protein to inhibit HBx-dependent viral DNA replication and gene transcription","volume":"35","author":"Kumar","year":"2024","journal-title":"Virusdisease"},{"key":"10.1016\/j.virol.2025.110438_bib35","series-title":"Transcription Factors, Handbook of Experimental Pharmacology Book Series","first-page":"377","article-title":"Hepatitis B virus X protein: structure-Function relationships and role in viral pathogenesis","author":"Kumar","year":"2004"},{"key":"10.1016\/j.virol.2025.110438_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2022.01.052","article-title":"All-trans retinoic acid inhibits HCV replication by downregulating core levels via E6AP-mediated proteasomal degradation","volume":"594","author":"Lee","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2025.110438_bib38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/v16091361","article-title":"Hepatitis B viral protein HBx: roles in viral replication and hepatocarcinogenesis","volume":"16","author":"Li","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110438_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cpdd.1197","article-title":"Pharmacokinetics, safety, and tolerability of the siRNA JNJ-73763989 in healthy Chinese adult participants","volume":"12","author":"Li","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.virol.2025.110438_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.1719","article-title":"A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery","volume":"17","author":"Li","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2025.110438_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gendis.2021.03.007","article-title":"Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease","volume":"9","author":"Li","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.virol.2025.110438_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1251248","article-title":"Ursolic acid: biological functions and application in animal husbandry","volume":"10","author":"Liu","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.virol.2025.110438_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00340-17","article-title":"HDM2 promotes NEDDylation of hepatitis B virus HBx to enhance its stability and function","volume":"91","author":"Liu","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5009\/gnl240023","article-title":"Toward a functional cure for hepatitis B","volume":"18","author":"Lok","year":"2024","journal-title":"Gut Liver"},{"key":"10.1016\/j.virol.2025.110438_bib46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"issue":"1 Suppl. l","key":"10.1016\/j.virol.2025.110438_bib48","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure","volume":"64","author":"Lucifora","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/2472630317751840","article-title":"Pharmacological review on asiatic acid and its derivatives: a potential compound","volume":"23","author":"Lv","year":"2018","journal-title":"SLAS Technol"},{"key":"10.1016\/j.virol.2025.110438_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/10245330701255130","article-title":"All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication","volume":"12","author":"Maeda","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.virol.2025.110438_bib52","article-title":"Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989","volume":"12","author":"Mak","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.virol.2025.110438_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib54","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1128\/JVI.79.15.9810-9820.2005","article-title":"Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression","volume":"79","author":"Melegari","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib56","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.3390\/v6114683","article-title":"Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system","volume":"6","author":"Minor","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110438_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.livres.2020.02.005","article-title":"Functional cure of chronic hepatitis B: efforts and prospects","volume":"4","author":"Mo","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.virol.2025.110438_bib60","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/v13081669","article-title":"All-trans retinoic acid exhibits antiviral effect against SARS-CoV-2 by inhibiting 3CLpro activity","volume":"13","author":"Morita","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110438_bib61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/v12030346","article-title":"The E3 ubiquitin ligase TRIM21 promotes HBV DNA polymerase degradation","volume":"12","author":"Mu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110438_bib62","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2025.110438_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev-med-080119-103356","article-title":"New therapeutics for hepatitis B: the road to cure","volume":"72","author":"Naggie","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.virol.2025.110438_bib65","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/med.22030","article-title":"Elimination of the hepatitis B virus: a goal, a challenge","volume":"44","author":"Pond\u00e9","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.virol.2025.110438_bib66","article-title":"Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen","volume":"4","author":"Qu","year":"2022","journal-title":"JHEP. Rep."},{"key":"10.1016\/j.virol.2025.110438_bib67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/liv.15805","article-title":"Targeted HBx gene editing by CRISPR\/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells","volume":"44","author":"Rawal","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.virol.2025.110438_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28578","article-title":"Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradation","volume":"95","author":"Ren","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib70","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.3390\/ijms24054964","article-title":"Relevance of HBx for hepatitis B virus-associated pathogenesis","volume":"24","author":"Schollmeier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2025.110438_bib71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110438_bib72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV transcription from cccDNA with Nitazoxanide by targeting the HBx-DDB1 interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2012.02.037","article-title":"Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer","volume":"320","author":"Shanmugam","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2025.110438_bib74","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.virs.2024.01.008","article-title":"Non-proteolytic ubiquitination of HBx controls HBV replication","volume":"39","author":"Sheng","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2025.110438_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virusres.2005.12.012","article-title":"Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice","volume":"119","author":"Shin","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2025.110438_bib76","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2174\/1568026623666230413094331","article-title":"Chronic hepatitis B infection: current and emerging therapeutic strategies","volume":"23","author":"Singh","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.virol.2025.110438_bib77","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1128\/jvi.71.8.6194-6199.1997","article-title":"Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants","volume":"71","author":"Sitterlin","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110438_bib78","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/cells11040741","article-title":"Hepatitis B viral protein HBx and the molecular mechanisms modulating the hallmarks of hepatocellular carcinoma: a comprehensive review","volume":"11","author":"Sivasudhan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.virol.2025.110438_bib104","doi-asserted-by":"crossref","first-page":"105107","DOI":"10.1016\/j.antiviral.2021.105107","article-title":"E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation","volume":"192","author":"Song","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2025.110438_bib79","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1743-422X-10-337","article-title":"In vitro inhibition of mumps virus by retinoids","volume":"10","author":"Soye","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110438_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105193","article-title":"A pharmacological review of dicoumarol: an old natural anticoagulant agent","volume":"160","author":"Sun","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.virol.2025.110438_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212233","article-title":"Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor","volume":"14","author":"Takeuchi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110438_bib82","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.celrep.2019.11.041","article-title":"Type-I-IFN-Stimulated gene TRIM5\u03b3 inhibits HBV replication by promoting HBx degradation","volume":"29","author":"Tan","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2025.110438_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56819-8","article-title":"Characterization and engineering of broadly reactive monoclonal antibody against hepatitis B virus X protein that blocks its interaction with DDB1","volume":"9","author":"Tao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110438_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2008.04.003","article-title":"Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways","volume":"80","author":"Trottier","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110438_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110438_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110065","article-title":"Furanocoumarins promote proteasomal degradation of viral HBx protein and down-regulate cccDNA transcription and replication of hepatitis B virus","volume":"595","author":"Tyagi","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110438_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.625169","article-title":"NEDD4 induces K48-linked degradative ubiquitination of hepatitis B virus X protein and inhibits HBV-associated HCC progression","volume":"11","author":"Wan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.virol.2025.110438_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199326","article-title":"PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation","volume":"341","author":"Wang","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2025.110438_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118848","article-title":"S6K1 inhibits HBV replication through inhibiting AMPK-ULK1 pathway and disrupting acetylation modification of H3K27","volume":"265","author":"Wang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.virol.2025.110438_bib105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/sj.gt.3300441","article-title":"Intracellular application of hairpin ribozyme genes against hepatitis B virus","volume":"4","author":"Welch","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2025.110438_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199273","article-title":"Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway","volume":"339","author":"Wen","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2025.110438_bib92","unstructured":"World Health Organization (WHO). Global hepatitis report 2024: action for access in low- and middle-income countries. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"10.1016\/j.virol.2025.110438_bib93","doi-asserted-by":"crossref","first-page":"20614","DOI":"10.3390\/molecules201119721","article-title":"Ursolic acid--A pentacyclic triterpenoid with a wide spectrum of pharmacological activities","volume":"20","author":"Wo\u017aniak","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2025.110438_bib94","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/jf1045624","article-title":"Suppression of hepatitis B virus x protein-mediated tumorigenic effects by ursolic Acid","volume":"59","author":"Wu","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.virol.2025.110438_bib95","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s11033-009-9855-1","article-title":"p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2","volume":"37","author":"Xian","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.virol.2025.110438_bib96","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S2468-1253(24)00237-1","article-title":"VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study","volume":"9","author":"Yuen","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2025.110438_bib97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/thno.20047","article-title":"A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.virol.2025.110438_bib98","doi-asserted-by":"crossref","first-page":"15157","DOI":"10.1074\/jbc.M910378199","article-title":"Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex","volume":"275","author":"Zhang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2025.110438_bib99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.virol.2025.110438_bib102","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2023.01.017","article-title":"Eliminating cccDNA to cure hepatitis B virus infection","volume":"78","author":"Zoulim","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:18:18Z","timestamp":1772342298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":91,"alternative-id":["S0042682225000509"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110438","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBx protein as a therapeutic target for functional cure of hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110438"}}